Fundraising Fox

Fresh Medical Laboratories

Salt Lake City, US · Delaware corporation

Founders & leadership

SC
Steven C ErorExecutive
MG
Michael GarffExecutive

Board

DT
Dennis TulaneBoard director
TT
Tim TreuBoard director
RR
Robert RaybouldBoard director
RM
Richard McKeownBoard director
CC
Clark CampbellBoard director
WA
Wayne AdamsBoard director
TM
Todd MorganBoard director

Reported raises · per SEC filings

Form D private placements

$7.3M disclosed across 4 of 5 rounds · 2015–2020

$182KraisedDec 2020 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Garff MichaelExecutive Officer, Director
  • Jared BauerExecutive Officer
  • Don PattersonDirector
  • Jim HoganDirector
  • David NielsenDirector
Offering amount
$6M
Amount sold
$182K
First sale
Dec 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$824KraisedMar 2018 · 4 investors · Biotechnology
Rule 506(c)
Officers, directors & promoters on the filing
  • J Scott NixonDirector
  • Robin L SmithDirector
  • Todd M MorganDirector
  • Michael A GarffExecutive Officer
  • Robert W RaybouldDirector
  • John C RuckdeschelDirector
  • Steven C ErorExecutive Officer, Director
  • Neil BerkleyDirector
  • Mark V AndersonExecutive Officer
Offering amount
$3M
Amount sold
$824K
Minimum investment
$25K
Sales commissions
$300K
Placement agents
Weild & Co.
First sale
Mar 2018
Incorporated
Corporation, Delaware
Federal exemptions
06c
Full filing on SEC EDGAR ↗
$5MraisedMay 2017 · 160 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert W. RaybouldDirector
  • Richard B. McKeownDirector
  • Jeffrey S. O'DriscollDirector
  • Clark A. CampbellDirector
  • John C RuckdeschelDirector
  • Robin L. SmithDirector
  • J. Scott NixonDirector
  • Michael A. GarffExecutive Officer
  • Aaron W StoutExecutive Officer
  • Todd M. MorganDirector
  • Steven C. ErorExecutive Officer, Director
Offering amount
$8.5M
Amount sold
$5M
Sales commissions
$280K
Placement agents
Weild & Co
First sale
Mar 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$1.3MraisedNov 2015 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Steven C ErorExecutive Officer
  • Dennis TulaneDirector
  • Jeffrey S O'DriscollDirector
  • Treu TimDirector
  • Robert RaybouldDirector
  • Michael GarffDirector
  • Richard McKeownDirector
  • Todd MorganDirector
  • Clark CampbellDirector
Offering amount
$1.3M
Amount sold
$1.3M
First sale
Nov 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$1MofferedFeb 2015 · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Dennis TulaneDirector
  • Tim TreuDirector
  • Robert RaybouldDirector
  • Steven C ErorExecutive Officer, Director
  • Michael GarffExecutive Officer
  • Richard McKeownDirector
  • Clark CampbellDirector
  • Wayne AdamsDirector
  • Todd MorganDirector
Offering amount
$1M
Minimum investment
$25K
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Fresh Medical Laboratories raised?
Fresh Medical Laboratories has disclosed $7.3M raised across 4 of its 5 known rounds.
Where is Fresh Medical Laboratories headquartered?
Fresh Medical Laboratories is headquartered in Salt Lake City, US.